News Listing

Congratulations/Gratulation

Congratulations to the NCCR RNA & Disease Principal Investigators Prof. Marc Bühler and Prof. Mariusz Nowacki for being awarded an ERC Consolidator Grant.

Wir gratulieren den NCCR RNA & Disease Gruppenleitern Prof. Marc Bühler und Prof. Mariusz Nowacki zum ERC...

Press Release FMI Basel
A better knowledge of RNA metabolism is key to understanding how RNAs regulate development and differentiation, and how their malfunction leads to disease. A team led by Helge Grosshans of the Friedrich Miescher Institute for Biomedical Research (FMI) has now identified a ...

Press Release / Medienmitteilung ETH Zürich
It has long been known that the protein TOR – Target of Rapamycin – controls cell growth and is involved in the development of diseases such as cancer and diabetes. Through a collaborative effort scientists from the ETH Zürich and from the Biozentrum of...

The first edition of the NCCR RNA & Disease Newsletter -The Messenger has been published:

  • Editorial Oliver Mühlemann
  • Technology platforms Where expertise meets researcher's needs
  • Portraits Welcome to the associate members of the NCCR RNA & Disease
  • Looking back 50 years ago / 100 years ago
  • Announcemen...

Hepatitis C virus (HCV) is a widespread pathogen that currently infects about 160 million people worldwide. Scientists at ETH Zurich supported by the NCCR in RNA and Disease have now visualized the process, in which the virus hijacks the protein production machinery of human cells, called...

Ein Interview mit Oliver Mühlemann wurde im UniPress Magazin der Universität Bern publiziert.

An interview with Martin Jinek has been published in this week's issue of Nature.

Press Release / Medienmitteilung ETH Zürich
There has been a lot of controversy in recent years over the issue of whether exogenous microRNA molecules can be absorbed from food and even have a physiological effect. A new study by ETH professor Markus Stoffel using mouse models settles the...

Podcast SRF Wissenschaftsmagazin
Ein Podcast aus der Sommerserie "Pioniere - Allen Voraus" des Wissenschaftsmagazins des Schweizer Radio und Fernsehens, welcher die Möglichkeiten, Risiken und Entdeckung der CRISPR Technologie beschreibt. Im Beitrag erläutert Martin Jinek (Assistenzprofessor...

FMI News Article
Marc Bühler and his group at the FMI have developed a new and more efficient way to generate embryonic stem cells in which a given gene can be deleted at will, so called conditional knockout cells. They used the engineered nuclease TALEN and a reporter to enrich cells that have ...